Cite

HARVARD Citation

    Finn, R. et al. (n.d.). O-027Pembrolizumab (Pembro) therapy vs best supportive care (BSC) in advanced hepatocellular carcinoma (HCC): KEYNOTE-240. Annals of oncology. p. . [Online]. 
  
Back to record